Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the durability of effect of milnacipran for the treatment of fibromyalgia in patients receiving long-term milnacipran treatment and to characterize the effects...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Forest Laboratories
Collaborators
NCT07226648 · Fibromyalgia
NCT07358754 · Fibromyalgia
NCT05901259 · Cerebral Palsy, Multiple Sclerosis, and more
NCT03759522 · Fibromyalgia, Chronic Fatigue Syndrome, and more
NCT07398417 · Fibromyalgia
Forest Investigative Site 062
Birmingham, Alabama
Forest Investigative Site 065
Birmingham, Alabama
Forest Investigative Site 012
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions